Original Article

You have full text access to this OnlineOpen article

Prevalence and predictors of antioxidant supplement use during breast cancer treatment

The Long Island Breast Cancer Study Project

  1. Heather Greenlee ND, PhD1,2,†,*,
  2. Marilie D. Gammon PhD3,
  3. Page E. Abrahamson PhD3,
  4. Mia M. Gaudet PhD4,
  5. Mary Beth Terry PhD1,2,
  6. Dawn L. Hershman MD, MS1,2,5,
  7. Manisha Desai PhD2,6,
  8. Susan L. Teitelbaum PhD7,
  9. Alfred I. Neugut MD, PhD1,2,5,
  10. Judith S. Jacobson DrPH, MBA1,2

Article first published online: 8 JUN 2009

DOI: 10.1002/cncr.24378

Issue

Cancer

Cancer

Volume 115, Issue 14, pages 3271–3282, 15 July 2009

Additional Information

How to Cite

Greenlee, H., Gammon, M. D., Abrahamson, P. E., Gaudet, M. M., Terry, M. B., Hershman, D. L., Desai, M., Teitelbaum, S. L., Neugut, A. I. and Jacobson, J. S. (2009), Prevalence and predictors of antioxidant supplement use during breast cancer treatment. Cancer, 115: 3271–3282. doi: 10.1002/cncr.24378

Author Information

  1. 1

    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York

  2. 2

    Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York

  3. 3

    Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina

  4. 4

    Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York

  5. 5

    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York

  6. 6

    Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York

  7. 7

    Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York

  1. †

    Fax: (212) 305-9413

*Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, Seventh Floor, New York, NY 10032

Publication History

  1. Issue published online: 15 JUL 2009
  2. Article first published online: 8 JUN 2009
  3. Manuscript Accepted: 31 DEC 2008
  4. Manuscript Revised: 28 DEC 2008
  5. Manuscript Received: 15 OCT 2008

Funded by

  • Lance Armstrong Foundation
  • National Cancer Institute and National Institutes of Environmental Health and Sciences. Grant Numbers: U01CA/ES66572, U01CA66572, CA52283, P30ES10126
  • National Cancer Institute. Grant Number: R25 CA09406

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (159K)

References

  • 1
    Lengacher CA, Bennett MP, Kip KE, et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2002; 29: 1445-1452.
  • 2
    VandeCreek L, Rogers E, Lester J. Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med. 1999; 5: 71-76.
  • 3
    Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000; 88: 674-684.
    Direct Link:
  • 4
    Henderson JW, Donatelle RJ. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med. 2004; 10: 52-57.
  • 5
    Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004; 22: 671-677.
  • 6
    Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat. 2006; 100: 219-227.
  • 7
    Boon H, Stewart M, Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000; 18: 2515-2521.
  • 8
    Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005 [serial online]. BMC Womens Health. 2007; 7: 4.
  • 9
    Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008; 26: 665-673.
  • 10
    Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park). 1999; 13: 1003-1008; discussion 1008, 1011-1012.
  • 11
    Hamilton KK. Antioxidant supplements during cancer treatments: where do we stand? Clin J Oncol Nurs. 2001; 5: 181-182.
  • 12
    Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev. 1999; 4: 304-329.
  • 13
    Lamson DW, Brignall MS. Antioxidants and cancer therapy II: quick reference guide. Altern Med Rev. 2000; 5: 152-163.
  • 14
    D'Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005; 55: 319-321.
    Direct Link:
  • 15
    Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integr Cancer Ther. 2004; 3: 310-322.
  • 16
    Simone CB 2nd, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 2. Altern Ther Health Med. 2007; 13: 40-47.
  • 17
    Simone CB 2nd, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med. 2007; 13: 22-28.
  • 18
    Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008; 100: 773-783.
  • 19
    Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008; 123: 1227-1239.
    Direct Link:
  • 20
    Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev. 1997; 23: 209-240.
  • 21
    Sangeetha P, Das UN, Koratkar R, Suryaprabha P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med. 1990; 8: 15-19.
  • 22
    Hellman S. Principles of radiation therapy. In: DeVitaVT, HellmanS, RosenbergSA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott; 1993.
  • 23
    Ladas EJ, Jacobson JS, Kennedy DD, Teel K, Fleischauer A, Kelly KM. Antioxidants and cancer therapy: a systematic review. J Clin Oncol. 2004; 22: 517-528.
  • 24
    Gammon MD, Neugut AI, Santella RM, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat. 2002; 74: 235-254.
  • 25
    Wyeth Consumer Healthcare. Centrum multivitamins [package insert]. Wilmington, Del: Wyeth Consumer Healthcare; 2002. Available at: http://www.centrum.com/multi/centrum.asp Accessed on June 24, 2002.
  • 26
    Council for Responsible Nutrition. Historical Comparison of RDIs, RDA, and DRIs, 1968 to Present for Vitamins. Washington, DC: Council for Responsible Nutrition; 2007.
  • 27
    Council for Responsible Nutrition. Historical Comparison of RDIs, RDA, and DRIs, 1968 to Present for Minerals. Washington, DC: Council for Responsible Nutrition; 2007.
  • 28
    Institute of Medicine, Committee on Use of Dietary Reference Intakes in Nutrition Labeling. Dietary Reference Intakes. Washington, DC: National Academy of Sciences; 2004.
  • 29
    Fink BN, Gaudet MM, Britton JA, et al. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res Treat. 2006; 98: 199-208.
  • 30
    Collett D. Modelling Survival Data in Medical Research. Boca Raton, Fla: Chapman & Hall/CRC; 2003.
  • 31
    Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc. 2004; 104: 942-950.
  • 32
    Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998; 16: 495-500.
  • 33
    Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early stage breast cancer. N Engl J Med. 1999; 340: 1733-1739.
  • 34
    Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004; 27: 1-19.
  • 35
    Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000; 179: 407-411.
  • 36
    Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002; 8: 477-485.
  • 37
    Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: A comprehensive review. Breast Cancer Res Treat. In press.
  • 38
    Bairati I, Meyer F, Gelinas M, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol. 2005; 23: 5805-5813.
  • 39
    Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst. 2005; 97: 481-488.
View Full Article (HTML) Get PDF (159K)